A study of triple negative breast cancer at a tertiary cancer care center in southern India
- PMID: 25506489
- PMCID: PMC4250994
- DOI: 10.4103/2141-9248.144917
A study of triple negative breast cancer at a tertiary cancer care center in southern India
Abstract
Background: Triple negative breast cancers (TNBCs) are a diverse and heterogeneous group of tumors that by definition lack estrogen and progesterone receptors and amplification of the HER-2 gene. The majority of the tumors classified as TNBCs are highly malignant, patients are usually young and only a subgroup of patients responds to conventional chemotherapy with a favorable prognosis. Various studies have been reported in western literature on TNBCs, all highlighting the poor prognosis of this subtype. However, extensive data from India is lacking.
Aim: The aim of this study was to analyze the epidemiological and clinical profile of TNBCs at our institute.
Materials and methods: This was the retrospective study carried out in Tertiary Cancer Care Center in South India. Case files of all breast cancer patients were reviewed from the hospital database registered in 1 year and TNBC patients were selected for the study. Patient's characteristic, treatment, and histological features were analyzed.
Results: A total of 322 patients were registered during the period of 1 year and 26% (84/322) of total patients were TNBC. Median age of presentation was 44.5 years. About 94% (79/84) of patients had first full-term delivery before the age of 30 years. The most common presenting symptom was left sided breast lump. Locally advanced and early breast cancer (EBC) was 51% (43/84) and 42% (36/84), respectively. Metastatic breast cancer was seen in five patients. The highest numbers of patients were node negative disease (36.9%) [31/84], followed by N1 30.95% (26/84). Most of the patients had high-grade tumor. 94% (34/36) of cases of EBC had undergone upfront modified radical mastectomy. Invasive ductal carcinoma was the predominant histology except one who had medullary carcinoma. Twenty-four patients received neoadjuvant chemotherapy (NACT). There was no pathological complete remission, but all patients responded to NACT. Metastatic disease was seen in five patients. All patients had bone metastasis.
Conclusions: TNBCs are highly aggressive subtype, with high grade with limited treatment options and very poor prognosis. Incidence is more in our country than the western literature. Even in our country also the incidence is varies in different region. TNBCs are significantly associated with young aged patients. There was a lack of association between tumor size and lymph node positivity.
Keywords: Breast cancer; Invasive ductal carcinoma; Triple negative.
Conflict of interest statement
Similar articles
-
Clinicopathological Profiles of and Patterns of Recurrence in Triple-Negative Breast Cancer Patients at a Cancer Care Center in Southern India.Cureus. 2024 Jul 5;16(7):e63886. doi: 10.7759/cureus.63886. eCollection 2024 Jul. Cureus. 2024. PMID: 39099998 Free PMC article.
-
Epidemiological and clinical profile of triple negative breast cancer at a cancer hospital in North India.Indian J Med Paediatr Oncol. 2013 Apr;34(2):89-95. doi: 10.4103/0971-5851.116185. Indian J Med Paediatr Oncol. 2013. PMID: 24049294 Free PMC article.
-
Triple-negative breast cancers: Are they always different from nontriple-negative breast cancers? An experience from a tertiary center in India.Indian J Cancer. 2017 Oct-Dec;54(4):658-663. doi: 10.4103/ijc.IJC_348_17. Indian J Cancer. 2017. PMID: 30082553
-
Overview of resistance to systemic therapy in patients with breast cancer.Adv Exp Med Biol. 2007;608:1-22. doi: 10.1007/978-0-387-74039-3_1. Adv Exp Med Biol. 2007. PMID: 17993229 Review.
-
Metaplastic Carcinoma of the Breast Is More Aggressive Than Triple-negative Breast Cancer: A Study From a Single Institution and Review of Literature.Clin Breast Cancer. 2017 Aug;17(5):382-391. doi: 10.1016/j.clbc.2017.04.009. Epub 2017 Apr 26. Clin Breast Cancer. 2017. PMID: 28529029 Free PMC article. Review.
Cited by
-
miR-655 suppresses epithelial-to-mesenchymal transition by targeting Prrx1 in triple-negative breast cancer.J Cell Mol Med. 2016 May;20(5):864-73. doi: 10.1111/jcmm.12770. Epub 2016 Jan 28. J Cell Mol Med. 2016. Retraction in: J Cell Mol Med. 2024 Apr;28(8):e18314. doi: 10.1111/jcmm.18314. PMID: 26820102 Free PMC article. Retracted.
-
Clinical Characteristics in Patients with Triple Negative Breast Cancer.Int J Breast Cancer. 2017;2017:1796145. doi: 10.1155/2017/1796145. Epub 2017 Aug 17. Int J Breast Cancer. 2017. PMID: 28912973 Free PMC article.
-
Prevalence of Molecular Subtypes of Breast Cancer in India: a Systematic Review and Meta-analysis.Indian J Surg Oncol. 2021 Apr;12(Suppl 1):152-163. doi: 10.1007/s13193-020-01253-w. Epub 2020 Oct 28. Indian J Surg Oncol. 2021. PMID: 33994741 Free PMC article. Review.
-
Clinicopathological Profiles of and Patterns of Recurrence in Triple-Negative Breast Cancer Patients at a Cancer Care Center in Southern India.Cureus. 2024 Jul 5;16(7):e63886. doi: 10.7759/cureus.63886. eCollection 2024 Jul. Cureus. 2024. PMID: 39099998 Free PMC article.
-
Meta-Analysis of Prevalence of Triple-Negative Breast Cancer and Its Clinical Features at Incidence in Indian Patients With Breast Cancer.JCO Glob Oncol. 2020 Jul;6:1052-1062. doi: 10.1200/GO.20.00054. JCO Glob Oncol. 2020. PMID: 32639876 Free PMC article.
References
-
- ICMR Cancer Registry 2004: Consolidated Reports of the PBCR and HBCR's. ICMR. 2001-2003:13.
-
- Badve S, Dabbs DJ, Schnitt SJ, Baehner FL, Decker T, Eusebi V, et al. Basal-like and triple-negative breast cancers: A critical review with an emphasis on the implications for pathologists and oncologists. Mod Pathol. 2011;24:157–67. - PubMed
-
- Nielsen TO, Hsu FD, Jensen K, Cheang M, Karaca G, Hu Z, et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res. 2004;10:5367–74. - PubMed
-
- Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA, et al. Triple-negative breast cancer: Clinical features and patterns of recurrence. Clin Cancer Res. 2007;13:4429–34. - PubMed
-
- Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006;295:2492–502. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous